Zynex, an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, will move its corporate headquarters to Englewood, Colorado.
The company's proprietary NeuroMove device is designed to help recovery of stroke and spinal cord injury patients. Zynex is also developing a new blood volume monitor for use in hospitals and surgery centers.
According to company officials, the new building is less than one mile from the existing headquarters and will expand the footprint from approximately 17,000 square feet to approximately 43,800 square feet, with a first right of refusal to occupy additional space in the building. The lease is for sixty-six months and can be extended by another two years until June 30, 2025.
Thomas Sandgaard, CEO said, "Our recent growth has made it necessary for us to lease larger office and manufacturing space to accommodate not only a higher level of activity as well as anticipated future growth.”
“We continue to outsource many functions, such as electronic assembly, in an effort to have as much flexibility in our growth as possible. We expect to move into the new space in January 2017," he added.